🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 66987P508 (prev. 66987P201 )
- Market Cap
- Micro Cap
- IPO
- 10/31/2007 · $4.00/share
Business: NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market with its two distinct product categories: the NEUTROX® family of products and the AGANOCIDE® compounds. The Neutrox family of products includes AVENOVA® for the eye care market, NEUTROPHASE® for wound care market, and CELLERX® for the aesthetic dermatology market.
Notes: AUTO-CRE
Company Contact
- CEO
- Michael Kazley
- CFO
- Andrew Jones
- Headquarters
- 2000 Powell Street, Suite 1150, Emeryville, CA 94608
- Phone
- 510-899-8800
- Fax
- 510-474-1577
- Investor Relations
- Jody Cain, LHA IR · 310-691-7100 · jcain@lhai.com